Drug intelligence / Profile preview

SPARC1401

Development stage
Discontinued
Lead developer
SPARC
Modality
Small Molecules
Administration
Topical
01

Overview

SPARC1401 is a topical gel formulation of tizanidine, a centrally acting muscle relaxant, developed by Sun Pharma Advanced Research Company (SPARC). It was specifically designed for the treatment of moderate to severe acute low back pain, with the goal of providing localized therapeutic effects while minimizing systemic side effects like sedation and hypotension that are common with oral tizanidine. SPARC1401 acts as an agonist at alpha-2 adrenergic receptors. The drug was evaluated in a Phase 2 randomized, double-blind, placebo- and active-controlled trial (NCT04101370) comparing three dose levels of the gel to oral tizanidine and placebo. In early 2022, SPARC announced that the development of SPARC1401 would be discontinued as the Phase 2 study did not meet its primary efficacy endpoint.

Other names
Tizanidine Topical Gel
02

Targets

ADRA2 (Alpha-2 adrenergic receptor family)ADRA2A (α2A)

Beyond the preview

Go deeper on SPARC1401.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPARC1401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call